BioSpace News Archive

Adial Pharmaceuticals, Inc. today provided a business update and reported its financial results for the first quarter of 2024.

PaxMedica, Inc. today announced it has timely filed a formal notice of appeal with the Nasdaq Office of Appeals and Review to reverse the decision of a Nasdaq Hearings Panel to delist the Company from Nasdaq.

Avenue Therapeutics, Inc. today reported financial results and recent corporate highlights for the first quarter ended March 31, 2024.

IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation vaccines, announces that an abstract describing a Phase 2 study with IMNN-001 plus bevacizumab (Avastin®) and neoadjuvant chemotherapy in advanced epithelial ovarian cancer patients has been accepted for presentation at the American Society of Clinical Oncology (ASCO) annual meeting.

TC BioPharm PLC announced that the company’s lead therapeutic TCB008 will be available to patients via a newly launched compassionate use program in the UK.

Actinium Pharmaceuticals, Inc. today announced it will host a KOL webinar on Monday, May 20, 2024, at 8:00 AM ET.

Researchers from Lund University and Enable Biosciences announced significant findings from their latest collaborative study, revealing the superior performance of the automated multiplex Antibody Detection by Agglutination-PCR technology over traditional Radiobinding Assays in identifying early stages of Type 1 Diabetes.

DCN Dx, a leading contract research organization for in vitro diagnostics, today acknowledges the FDA’s Emergency Use Authorization (EUA) of the WELLlife™ COVID-19/Influenza A&aB Test, developed by Wondfo USA.

Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, announced its intention to merge with Absolute Biotech, a unified company of multiple antibody-centric brands.

Thermo Fisher Scientific Introduces Array-based Solution for Extended Blood Type Research to Support Future Advancements Toward Safer Transfusions.